CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ½ÅÁ¤¿ø
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ³úÀüÁõ(°æ·Ã¼ºÁúȯ)/½Ç½Å/¼ö¸éÀå¾Ö/ÀÎÁöÀúÇÏ/³ú¿°
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
90 (±¹³»)±âŸ ±Þ¼º ¹ÙÀÌ·¯½º ³ú¿°
89 (±¹¿Ü)SCI The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease
88 (±¹¿Ü)SCIE Plasma total homocysteine and the methylenetetrahydrofolate reductase 677C/T polymorphism do not contribute to the distribution of cervico-cerebral atherosclerosis in ischaemic stroke patients
87 (±¹¿Ü)SCI Association between tumor necrosis factor-alpha (-308G-A and -238G-A) polymorphisms and homocysteine levels in patients with ischemic strokes and silent brain infarctions
86 (±¹³»)KCI ¾È±¸ ³»Àü Àå¾Ö¸¦ º¸ÀÎ ¿ÜÁ÷±Ù ¾È¿Í ±ÙÀ°¿°
85 (±¹¿Ü)SCIE Myotonic dystrophy type I combined with X-linked dominant Charcot-Marie-Tooth neuropathy
84 (±¹¿Ü)SCIE Association of endothelial nitric oxide synthase polymorphisms and haplotypes with ischemic stroke in Korean individuals with or without diabetes mellitus
83 (±¹³»)KCI Á¶Ç÷Áٱ⼼Æ÷ ÀÌ½Ä È¯ÀÚ¿¡¼­ Á¦6Çü ÀÎü Ç츣Æ佺¹ÙÀÌ·¯½º°¨¿°¿¡ ÀÇÇÑ º¯¿¬³ú¿°
82 (±¹¿Ü)SCI The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke
81 (±¹¿Ü)SCI Endothelial nitric oxide synthase gene polymorphisms and the risk of silent brain infarction
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729